Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,617 | -14,759 | -6,981 | -29,844 | -26,023 |
| Depreciation Amortization | 1,949 | 1,288 | 641 | 2,580 | 1,939 |
| Accounts receivable | -1,417 | 254 | -193 | 1,046 | 272 |
| Accounts payable and accrued liabilities | -98 | -209 | -424 | -574 | -1,001 |
| Other Working Capital | -990 | 534 | -493 | -771 | -1,140 |
| Other Operating Activity | 3,521 | 1,557 | 1,206 | 3,885 | 4,532 |
| Operating Cash Flow | $-15,652 | $-11,335 | $-6,244 | $-23,678 | $-21,421 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,279 | -7,139 | 637 | 14,445 | 14,693 |
| PPE Investments | -673 | -457 | -333 | -1,171 | -972 |
| Investing Cash Flow | $-3,952 | $-7,596 | $304 | $13,274 | $13,721 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 10,000 | 10,000 |
| Common Stock Issued | 8,404 | 336 | 268 | 28 | 7 |
| Other Financing Activity | 9,895 | 10,164 | -215 | -685 | -308 |
| Financing Cash Flow | $18,299 | $10,500 | $53 | $9,343 | $9,699 |
| Exchange Rate Effect | -344 | -316 | -93 | -2,284 | -2,464 |
| Beginning Cash Position | 28,980 | 28,980 | 28,980 | 32,325 | 32,325 |
| End Cash Position | 27,331 | 20,233 | 23,000 | 28,980 | 31,860 |
| Net Cash Flow | $-1,649 | $-8,747 | $-5,980 | $-3,345 | $-465 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,652 | -11,335 | -6,244 | -23,678 | -21,421 |
| Capital Expenditure | -699 | -483 | -359 | -1,171 | -972 |
| Free Cash Flow | -16,351 | -11,818 | -6,603 | -24,849 | -22,393 |